© 2026 ULYSTAR – Social Networking App, Professional Networking Platform & Jobs in India
English
Recent Updates
-
The Global Biosimilar Market , Key Insights, Growth Drivers & Future Trends | 2024 -2032The global biosimilar market reached a value of USD 24.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.60% from 2024 to 2032. This significant growth trajectory is driven by the increasing demand for affordable biopharmaceutical alternatives, the rising prevalence of chronic diseases, and the rapid advancements in biotechnology. By 2032, the market is...0 Comments 0 Shares 2K Views 0 Reviews1
Please log in to like, share and comment! -
Global Recombinant DNA Technology Market , outlook , Market, Trends & Growth 2024-2032The global recombinant DNA technology market attained a value of about USD 740.66 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 6.8% to reach nearly USD 1338.54 billion by 2032. Global Recombinant DNA Technology Market This growth is driven by advancements in genetic engineering, increasing demand for biopharmaceuticals, and the rising...0 Comments 0 Shares 2K Views 0 Reviews1
-
Hereditary Angioedema (HAE) Drug Pipeline AnalysisAccording to the Rare Disease Advisor, the prevalence of hereditary angioedema (HAE) is estimated to be between 1 in 10,000 and 1 in 50,000. Every year, HAE episodes cause 15,000 to 30,000 visits to emergency rooms in the United States. It makes up around 2% of all cases of clinical angioedema, which afflicts about 20% of the population. Hereditary Angioedema (HAE) Drug Pipeline Analysis...0 Comments 0 Shares 3K Views 0 Reviews1
-
Unresectable Melanoma Drug Pipeline AnalysisMelanoma refers to a type of skin cancer that is primarily caused by exposure to ultraviolet (UV) light. While melanoma accounts for only 1% of all skin cancers, it is responsible for a significant proportion of cancer-related deaths. If not detected or treated early, melanoma can progress into a metastatic disease, spreading to other parts of the body and becoming far more difficult to treat....0 Comments 0 Shares 2K Views 0 Reviews1
-
Wilson Disease Drug Pipeline AnalysisAccording to the American Liver Foundation, about 1 in 30,000 people in the United States are diagnosed with Wilson Disease, a rare genetic disorder that leads to copper accumulation in vital organs, particularly the liver, brain, and corneas. This condition is caused by mutations in the ATP7B gene, responsible for copper transport in the body. Additionally, Wilson Disease Drug Pipeline...0 Comments 0 Shares 2K Views 0 Reviews1
More Stories